We work with low- and middle-income countries around the world to tackle antimicrobial resistance and support the implementation of their AMR National Action Plans.
In November 2020, the WHO and ICARS signed a Memorandum
of Understanding (MoU) paving the way for joint efforts to
strengthen One Health implementation and operational research.
Within the framework of the MoU, ICARS is seconding an expert
from our team to the AMR Global Coordination Department. Over
the next two years, the secondee will lead and coordinate the
development and prioritization of a One Health implementation
and operational research agenda for AMR.
In December 2020, ReAct and ICARS kicked off their collaboration with an MoU sealed with a virtual elbow-bump. Our joint efforts will focus on AMR mitigation in LMICs through an interdisciplinary approach that inspires action. ICARS also aims to use the ReAct Toolbox as a resource in its advocacy and project development efforts.
We partnered with the Joint Programming Initiative
on Antimicrobial Resistance (JPIAMR) and over 27 countries to
fund researchers from LMICs in the transnational call for “One
Health interventions to prevent or reduce the development and
transmission of AMR”. With LMICs being in need of sustainable
interventions, it is crucial that local researchers have the
opportunity to participate in and benefit from the knowledge
gained though such consortia. ICARS is contributing up to one
million Euro for LMIC-based researchers responding to this call.
